AG
KALA icon

Algert Global’s KALA BIO KALA Stock Holding History

Algert Global’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16
Closed -$54K – 1299
2022
Q1 		$54K Buy
+16
New +$41.9K ﹤0.01% 1138
2021
Q4 		– Sell
-9
Closed -$62K – 1038
2021
Q3 		$62K Sell
9
-20
-69% -$173K 0.01% 997
2021
Q2 		$384K Buy
29
+23
+383% +$362K 0.13% 228
2021
Q1 		$94K Buy
+6
New +$117K 0.03% 414
2020
Q1 		– Sell
-19
Closed -$174K – 467
2019
Q4 		$174K Hold
19
– – 0.05% 328
2019
Q3 		$180K Buy
+19
New +$231K 0.07% 289

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Algert Global's KALA Position: Q2 2022 in Review

Algert Global sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 16 shares — an estimated $54K sold.

Algert Global first reported a position in KALA in Q3 2019 and held it in 6 quarters. The position peaked at $384K in Q2 2021. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Algert Global reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Algert Global sold 16 KALA BIO shares in Q2 2022, an estimated $54K.
  • Algert Global first reported a position in KALA BIO in Q3 2019 and held it in 6 quarters.
  • Algert Global's KALA BIO position peaked at $384K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.